Riskpilot← Back to searchSign inGet full accessINTRAMEDIC HOLDING A/S
A/SActiveCVR 29199728Egebækvej 98Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2005— employees
Revenue 2025
DKK -67K
-80% vs 2024
EBITDA margin
100.0%
+80% vs 2024
Equity ratio
73.4%
Financial strength
Net profit 2025
DKK 12,9M
+51% vs 2024
| Revenue | DKK -67K | -80% |
| EBITDA | DKK -67K | +80% |
| Net profit | DKK 12,9M | +51% |
| Total assets | DKK 30,2M | +27% |
| Equity | DKK 22,2M | +19% |
| Employees | — | — |
Legal name
INTRAMEDIC HOLDING A/S
CVR number
29199728
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. december 2005
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af 2 bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at være holdingselskab til Intramedic A/S og Intramedic AB, samt hermed beslægtet virksomhed.
Address
Egebækvej 98
Email
mn@intramedic.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2006 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | -101 | -38 | -49 | -31 | -36 | -195 | -31 | -34 | -1.485 | -395 | -954 | -258 | -329 | -67 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | — | — | — | — | — | -101 | -38 | -49 | -31 | -36 | -195 | -31 | -34 | -1.485 | -395 | -954 | -258 | -329 | -67 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | — | — | — | — | — | -101 | -38 | -49 | -31 | -36 | -195 | -31 | -34 | -1.485 | -395 | -954 | -258 | -329 | -67 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 3.505 | 6.167 | 7.538 | 7.260 | 5.218 | 6.324 | 8.250 | 9.582 | 6.901 | 13.396 | 13.364 | 4.982 | 8.874 | 12.854 |
| Profit before tax | — | — | — | — | — | 3.595 | 6.341 | 7.489 | 7.228 | 5.183 | 6.129 | 8.220 | 9.548 | 5.415 | 13.001 | 12.411 | 4.724 | 8.546 | 12.787 |
| Tax | -0 | -0 | -0 | -0 | -0 | 96 | 106 | 6 | -49 | -95 | -70 | 44 | -53 | -85 | -154 | -265 | 85 | 29 | -77 |
| Net profit | — | — | — | — | — | 3.499 | 6.235 | 7.483 | 7.277 | 5.278 | 6.199 | 8.175 | 9.601 | 5.501 | 13.155 | 12.676 | 4.639 | 8.516 | 12.864 |
| Item | 2006 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 24.974 | 27.375 | 27.325 | 26.574 | 22.500 | 22.099 | 22.707 | 25.532 | 22.258 | 30.671 | 33.189 | 29.955 | 23.789 | 30.244 |
| Equity | — | — | — | — | — | 17.984 | 18.298 | 15.436 | 17.512 | 6.835 | 7.619 | 9.192 | 11.737 | 7.752 | 18.292 | 17.614 | 20.221 | 18.592 | 22.199 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 638 | 696 | 1.743 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 6.990 | 9.076 | 11.889 | 9.062 | 15.666 | 14.480 | 13.515 | 13.794 | 14.505 | 12.379 | 15.575 | 9.096 | 4.500 | 6.302 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 6.990 | 9.076 | 11.889 | 9.062 | 15.666 | 14.480 | 13.515 | 13.794 | 14.505 | 12.379 | 15.575 | 9.734 | 5.196 | 8.045 |
EBITDA margin
-6733600.0%
This company
15.8%
Market median
-42617822% vs market
20062025
Equity ratio
73.4%
This company
38.2%
Market median
+92% vs market
20062025
Return on equity
57.9%
This company
18.4%
Market median
+215% vs market
20062025
Net profit margin
1286359500.0%
This company
8.1%
Market median
+15880981381% vs market
20062025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20062025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20062025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
- Annual report 2011Filed via CVR / Virk · Period 2010-05-01 – 2011-04-30
- Annual report 2010Filed via CVR / Virk · Period 2009-05-01 – 2010-04-30
- Annual report 2009Filed via CVR / Virk · Period 2008-05-01 – 2009-04-30
- Annual report 2008Filed via CVR / Virk · Period 2007-05-01 – 2008-04-30
- Annual report 2006Filed via CVR / Virk · Period 2005-12-08 – 2006-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NC Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
MS Management | Management | 2005 | — | — |
MJ Management | Management | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2008 | — | — | |
| Deputy Chairman | 2006 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2017 | — | — | |
| Chairman | 2006 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
IM INVEST ApS | Company | 33.3% | 33.3% | 2017 |
CARDIOPHARMA ApS | Company | 20.0% | 20.0% | 2017 |
IM Club ApS | Company | 15.0% | 15.0% | 2015 |
INTRAMEDIC HOLDING A/S | Company | 15.0% | 15.0% | 2017 |
| Individual | 5.0% | 5.0% | 2013 | |
EDSVIKEN ApS | Company | 25.0% | 25.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CARDIOPHARMA ApS
INTRAMEDIC HOLDING A/S Board members of INTRAMEDIC HOLDING A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Christian Fischer Petersen | Chief Executive Officer | 0 companies |
| Morten Strømsted | Management | 0 companies |
| Michael Jørgsholm | Management | 0 companies |
| Thomas Francis Beckett | Board of Directors | 0 companies |
| Peter Gustavsson | Board of Directors | 0 companies |
| Tom Jacobsgaard | Deputy Chairman | 0 companies |
| Svenn Poulsen | Board of Directors | 0 companies |
| Casper Lyngbo Hjort | Chairman | 0 companies |
| Frans Boch | Chairman | 0 companies |
| Gert Sigh Christensen | Board of Directors | 0 companies |